Ensysce Biosciences, Inc. (ENSC) Operating cash flow 2018–2025
Ensysce Biosciences, Inc. (ENSC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.8MFY2025 · since FY2018: -$1.2M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -4.0% |
| FY2024 | -$7.5M | +30.4% |
| FY2023 | -$10.8M | +39.7% |
| FY2022 | -$17.9M | -117.0% |
| FY2021 | -$8.2M | -560.8% |
| FY2020 | -$1.2M | +12.5% |
| FY2019 | -$1.4M | -15.1% |
| FY2018 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net incomeENSC Net marginENSC Gross profitENSC Gross marginENSC Operating incomeENSC Operating marginENSC Free cash flowENSC Capital expendituresENSC Return on equityENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →